Patent · US Active

Anti-VEGFR-3 antibody compositions

US8784818B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 7, 2013
Grant dateJul 22, 2014
Priority date
Expiry dateMay 7, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides anti-VEGFR-3 monoclonal antibodies, pharmaceutical compositions containing said antibodies and uses of said antibodies in the treatment of disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.